CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BL PharmTech Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BL PharmTech Corp
7F, A Dong, 767, Sinsu-ro, Suji-gu
Phone: +82 234014490p:+82 234014490 YONGIN, 16827  South Korea Ticker: 065170065170
Business Summary
BL PharmTech Corp, formerly Next BT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of health foods. The Company operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2099 Food preparations, not elsewhere classified
2835 In vitro and in vivo diagnostic substances
2844 Perfumes, cosmetics, and other toilet preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Hyo RimLee 67 3/30/2015 3/30/2015
Internal Auditor Gwang YilLee 55 3/27/2009 3/27/2009
Director Bong NamKim 40 3/29/2013 3/29/2013
3 additional Officers and Directors records available in full report.

Business Names
Business Name
065170
NRD Co., Ltd.
Rexgene Biotech Co., Ltd.

General Information
Number of Employees: 42 (As of 12/31/2015)
Outstanding Shares: 88,968,752 (As of 9/30/2024)
Shareholders: 19,218
Stock Exchange: KDQ
Fax Number: +82 24005796


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024